EW (Edwards) נכסי החברה

The linear price action on the chart demonstrates the growth of total assets for Edwards Lifesciences (EW), which stands at 13685.75. Market capitalization is supported by costly developments in cardiac surgery, where high patent values facilitate global expansion. The status of a dominant supplier of heart prostheses creates long-term brand loyalty among clinics. Total control over physician training and stringent regulatory standards make this technological environment virtually inaccessible to new entrants.

Edwards Lifesciences operates high-tech resources to produce unique cardiac surgery solutions. This indicator, calculated inversely via ROA, reflects the total value of assets and liabilities, forming the basis for assessing real capital. The investor compares market capitalization with the volume of resources to avoid overpaying for control. The current total asset value of 13685.75 confirms the resource capacity that allows the company to maintain its pricing power.